Helping our clients move healthcare and technology forward
Deal Announcement
SVB Securities Deal Announcement: Eledon Pharmaceuticals
SVB Securities Serves as Lead Placement Agent for Eledon Pharmaceuticals’ (Nasdaq: ELDN) Up to $185 Million Private Placement
Published May 01, 2023More Deal Announcement
View all Deal Announcement
Deal Announcement
SVB Securities Serves as Joint Bookrunner for Guardant Health’s (Nasdaq: GH) $350 Million Follow-On Offering
May 2023
Deal Announcement
SVB Securities Serves as Lead Capital Markets Advisor and Lead Placement Agent to Forbion European Acquisition Corp. (Nasdaq: FRBN) in Connection with Its Proposed Merger with enGene, Inc. and $135 Million Financing
May 2023
Deal Announcement
SVB Securities Serves as Joint Bookrunner for agilon health’s (Nasdaq: AGL) $1,868 Million Follow-On Offering
May 2023
Featured Intelligence
View additional intelligenceSee also:
Capital Markets
Growth-oriented companies need an experienced partner with demonstrated capital-raising power
Learn MoreEquity Research
Investors benefit from our depth of coverage in healthcare and technology
Learn More